Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ResMed Inc (NYSE:RMD)

61.37
Delayed Data
As of 4:04pm ET
 +1.03 / +1.71%
Today’s Change
50.77
Today|||52-Week Range
70.90
+14.30%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$8.5B

Company Description

ResMed, Inc. engages in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders including sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its product portfolio includes obstructive sleep apnea, and other respiratory disorders that occur during sleep. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Contact Information

ResMed, Inc.
9001 Spectrum Center Boulevard
San Diego California 92123
P:(858) 836-5000
Investor Relations:
(858) 836-5971

Employees

Shareholders

Mutual fund holders33.53%
Other institutional32.94%
Individual stakeholders1.75%

Top Executives

Mick FarrellChief Executive Officer & Director
Rob DouglasPresident & Chief Operating Officer
Brett A. SandercockChief Financial Officer
Frank LacagninaChief Information Officer
David PendarvisSecretary & Chief Administrative Officer